Indutrade has signed an agreement to acquire all shares in the German company Createc GmbH & Co. KG, www.createc.com/eng, with annual sales of approximately EUR 23 million (SEK 250 million).
Createc designs, manufactures and sells high-performance composite components for medical instruments, sealing solutions, and pump bearing applications. Based on its proprietary composite material platforms, the company addresses mission-critical applications with high regulatory and technical requirements. The product offering includes targeting devices and fixation systems for orthopaedic and trauma applications, specially formulated compounds, O-rings and sealing solutions. Customers are mainly found in the medical technology industry, energy sector and process industry.
Createc was founded in 2006, has 35 employees and is located in Friedrichshafen, Germany. The company has a strong position in its niche and long-lasting relationships with its customers and suppliers.
The closing took place on 2 June and Createc will be included in Indutrade's Business Area Life Science. The acquisition is Indutrade's sixth in 2026 and is expected to have a marginally positive impact on Indutrade's earnings per share.